Blood Test Identifies Long COVID
Author Information
Author(s): Missailidis Daniel, Ebrahimie Esmaeil, Dehcheshmeh Manijeh Mohammadi, Allan Claire, Sanislav Oana, Fisher Paul, Gras Stephanie, Annesley Sarah J.
Primary Institution: La Trobe University
Hypothesis
Can a blood-based mRNA signature distinguish individuals with Long COVID from those who have recovered from COVID-19?
Conclusion
The study found that specific gene expressions in blood can effectively differentiate Long COVID patients from those who have recovered.
Supporting Evidence
- Seventy genes were identified as significantly up- or down-regulated in Long COVID samples.
- Principal Component Analysis showed that LILRB1 and LILRB2 expression discriminated Long COVID samples from COVID recovered samples.
- Most differentially expressed genes were downregulated in Long COVID individuals.
Takeaway
Researchers found that people with Long COVID have different gene expressions in their blood compared to those who have fully recovered, which could help in diagnosing the condition.
Methodology
RNA-Seq was used to analyze the transcriptomes of PBMCs from 7 Long COVID and 7 COVID recovered individuals.
Potential Biases
Potential biases due to small sample size and specific participant selection.
Limitations
The study is based on a small pilot cohort and requires validation in larger groups.
Participant Demographics
Participants included 7 Long COVID and 7 COVID recovered individuals, average age 41 for Long COVID and 45 for recovered, with a higher percentage of females.
Statistical Information
P-Value
FDR p = 0.005 for LILRB1
Statistical Significance
pFDR < 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website